aXichem Q1’22: Taking Steps in the Right Direction - Redeye
Redeye provides its comments on aXichem’s Q1’22 report. With increasing activity in both segments as well as pending feed additive approvals in both the EU and Brazil, aXichem is preparing for scaling up its commercial activities.
ANNONS
Redeye provides its comments on aXichem’s Q1’22 report. With increasing activity in both segments as well as pending feed additive approvals in both the EU and Brazil, aXichem is preparing for scaling up its commercial activities.